Mednet Logo
HomeMedical Oncology
Medical Oncology

Medical Oncology

Physician insights on cancer treatment protocols, immunotherapy, targeted therapies, and clinical trial updates.

Recent Discussions

What is your approach to bone imaging in MGUS?

1
1 Answers

Mednet Member
Mednet Member
Medical Oncology · Mayo Clinic Rochester

Excellent question. For low-risk MGUS (M-spike <1.5 g/dL, normal serum free light chain ratio, and an IgG type protein), it is reasonable to forego any bone imaging in the absence of any relevant bone-related symptoms. The rate of bone involvement in patients with an M-spike of 1.5 g/dL was noted to...

How do you approach the management of a patient with symptomatic iron deficiency anemia who is intolerant of iron?

1
4 Answers

Mednet Member
Mednet Member
Hematology · Georgetown University School of Medicine

Oral iron will not work. I would bet my last dollar there was no anaphylaxis but rather an imprudently treated minor infusion reaction which is the cause of ostensible “anaphylaxis” over 99% of the time. You can’t verify that it was real because I can assure you: It was not. They did not do a trypt...

Do you routinely refer young patients with iron deficiency anemia for GI evaluation?

1
1 Answers

Mednet Member
Mednet Member
Hematology · Georgetown University School of Medicine

The answer is no, I do not. However, if after iron repletion deficiency persists, then I do. But as for pregnancy, unless there has been a precipitous and proven drop, I would definitely not do a GI workup during pregnancy.

Do you routinely refer young patients with iron deficiency anemia for GI evaluation?

1
1 Answers

Mednet Member
Mednet Member
Hematology · Georgetown University School of Medicine

The answer is no, I do not. However, if after iron repletion deficiency persists, then I do. But as for pregnancy, unless there has been a precipitous and proven drop, I would definitely not do a GI workup during pregnancy.

How would you manage symptomatic iron deficiency in patients with PV on frequent phlebotomies?

2 Answers

Mednet Member
Mednet Member
Medical Oncology · Taussig Cancer Institute

While iron deficiency by itself is not harmful, if someone has symptomatic iron deficiency, you could consider them intolerant to phlebotomies, and start a cytoreductive agent. Then, over time they can replete their iron stores. In some patients who are very symptomatic from their iron deficiency, I...

How would you manage symptomatic iron deficiency in patients with PV on frequent phlebotomies?

2 Answers

Mednet Member
Mednet Member
Medical Oncology · Taussig Cancer Institute

While iron deficiency by itself is not harmful, if someone has symptomatic iron deficiency, you could consider them intolerant to phlebotomies, and start a cytoreductive agent. Then, over time they can replete their iron stores. In some patients who are very symptomatic from their iron deficiency, I...

How soon after initiating oral anticoagulation therapy for atrial fibrillation can it be interrupted for surgery or procedures?

2
1 Answers

Mednet Member
Mednet Member
Cardiology · Ohio State University Cardiovascular Medicine

As with most things medical, multiple answers. If a patient walks into my office for preOp "clearance" and behold, they are in atrial fib, but asymptomatic, then it would depend on the urgency of their surgery. If elective, then you have time to work up his atrial fib and look for a reversal cause (...

For a patient with NSCLC harboring an EGFR or ALK mutation that transforms into SCLC, would you add immunotherapy to chemotherapy or avoid immunotherapy given the tumor's EGFR/ALK origin?

1
3 Answers

Mednet Member
Mednet Member
Medical Oncology · Yale School of Medicine

I typically avoid immunotherapy and continue the targeted therapy, such as osimertinib, with the chemotherapy.

For a patient with May-Thurner syndrome and DVT, would you recommend anticoagulation for 3-6 months or indefinitely?

4
4 Answers

Mednet Member
Mednet Member
Hematology · Keck School of Medicine of USC

This is a very good question, there is little data on this and there are only a few case series. One case series of 8 patients showed a 25% risk of recurrence in one year with May-Thurner syndrome but too small of a sample to really know what the risk is, plus this probably included a heterogenous m...

How would you palliate a large, symptomatic vaginal melanoma recurrence with limited small pelvic lymph node metastases?

5 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

Palliation. Treat problems that are symptomatic. No expensive systemic work up. Pall RT to the pelvis if it’s symptomatic. 30 Gy/10 fractions, 25 Gy/5 fractions, or 20 Gy/2 fractions with a 1 week inter-fraction interval. Apologize for the lengthy response.